हिन्दी
English
मराठी
বাংলা
தமிழ்
മലയാളം
ગુજરાતી
తెలుగు
ಕನ್ನಡ
ଓଡ଼ିଶା
Business
Tech
World
Health
NEWS
VIDEOS
PHOTOS
Web Stories
LIVE TV
GO
Latest
Assembly Election
India
Ahmedabad
Bengaluru
Chennai
Hyderabad
Kolkata
Mumbai
Pune
Cricket
Success Story
Entertainment
Hollywood
Music
Bollywood
Television
Regional
Movie Review
Lifestyle
Relationship
Travel
Food & Recipes
Fashion
Culture
Spirituality
Business
Economy
Markets
Companies
Real Estate
International Business
Personal Finance
Automobile
Technology
Gadgets
Gaming
Internet & Social Media
Apps
Mobiles
World
Asia
Africa
Americas
Australia-Oceania
Europe
Auto
Mobility
Viral
Diabytes
Fables of Facades
Archived Videos
Newsletter
Fables of Facades
Latest
Assembly Election
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Latest
Assembly Election
India
Cricket
Success Story
Entertainment
Lifestyle
Business
World
Auto
Mobility
Viral
Fables of Facades
Archived Videos
Advertisement
X
News
Syngene
Syngene News
Syngene
22 Jun 2015
Syngene gets nod to raise foreign investment to 44%
Syngene, a subsidiary of Biocon, on Monday said it has received the Foreign Investment Promotion Board (FIPB) approval for raising foreign investment in the company to 44 percent from the earlier approved 10 percent.
Foreign direct investment
17 Jun 2015
Govt approves FDI worth Rs 4,000 cr in pharma sector
Proposals for foreign direct investment amounting to around Rs 4,000 crore by four pharma and medical devices firms, including Torrent Pharmaceuticals and Biocon's research services arm Syngene, were on Wednesday approved by the government.
Biocon
23 Apr 2015
Biocon files IPO prospectus for R&D arm Syngene
Biotech firm Biocon Ltd has filed a prospectus for the initial public offering of its USD 600 million research and development arm, Syngene, it said on Thursday.
Biocon
22 Apr 2015
Biocon files prospectus for Syngene IPO to raise Rs 600 cr
Biotechnology major Biocon Wednesday filed prospectus with market regulator SEBI for the initial public offer of its research arm Syngene through which aims to raise around Rs 600 crore that will be used to fund its R&D programmes.
biotechnology
01 Apr 2015
Biocon arm Syngene appoints Peter Bains as CEO
Biotechnology major Biocon's custom research arm Syngene has appointed Peter Bains as its Chief executive Officer (CEO).
Biocon Ltd
23 Jan 2015
Biocon says to take Syngene unit public
Biocon Ltd will list its research services business arm Syngene by selling up to 15 percent stake in a public offer, the company said, after reporting third-quarter earnings.
Biocon
12 Jan 2015
Biocon completes 10% stake sale in Syngene
Biotechnology major Biocon on Monday concluded sale of 10 percent stake in its research arm Syngene for Rs 380 crore to IVF Trustee Company Private Ltd.
671108
1
0
Loading...
Trending news
DNA Video
DNA: Indian Navy Successfully Tests Long-Range Missile
DNA Video
DNA: Government’s Shocking Statement on Indian Railways' Blankets
DNA Video
DNA: Shocking ‘Vote Jihad’ Allegation Surfaces in Delhi
DNA Video
DNA: Eknath Shinde Steps Back, BJP to Decide CM
DNA Video
DNA: Where Is Bushra Bibi Amidst Pakistan’s Chaos?
DNA Video
DNA: Chhattisgarh Couple Promotes Helmet Safety at Wedding, Video Goes Viral
DNA Video
DNA: IIT Kanpur Develops ‘Invisible’ Shield for Indian Army!
DNA Video
DNA: AIMPLB's 'provocative plan' on Waqf leaked!
DNA Video
DNA: Sambhal riots- shocking revelations in police FIR
DNA Video
DNA: Violence Erupts in Bangladesh After ISKCON Monk Chinmoy Das’ Arrest
Subscribe Now
×
Enroll for our free updates
Please enter full name.
Please enter valid email address.
https://zeenews.india.com/
Subscribe Now
Thank you
×
Cookies Settings
Reject
Accept Cookies
NEWS ON ONE CLICK